Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:businessModel |
Private
|
| gptkbp:CEO |
gptkb:Satish_Mehta
|
| gptkbp:country |
gptkb:India
|
| gptkbp:exportedTo |
over 70 countries
|
| gptkbp:foundedBy |
gptkb:Satish_Mehta
|
| gptkbp:foundedYear |
1983
|
| gptkbp:headquartersLocation |
gptkb:Pune
|
| https://www.w3.org/2000/01/rdf-schema#label |
Emcure Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:listedOnStockExchange |
No
|
| gptkbp:manufacturingFacilities |
gptkb:India
|
| gptkbp:market |
Global
|
| gptkbp:notableEvent |
Developed COVID-19 vaccine candidate
|
| gptkbp:notablePerson |
gptkb:Namita_Thapar
|
| gptkbp:notableProduct |
ZyCoV-D (in collaboration with Zydus Cadila)
|
| gptkbp:numberOfEmployees |
6000+
|
| gptkbp:products |
Active pharmaceutical ingredients
Pharmaceutical formulations |
| gptkbp:subsidiary |
gptkb:Heritage_Pharmaceuticals
|
| gptkbp:website |
https://www.emcure.com/
|
| gptkbp:bfsParent |
gptkb:Pimpri-Chinchwad
gptkb:Pune,_Maharashtra,_India |
| gptkbp:bfsLayer |
6
|